Jyong Biotech Ltd. (MENS)

Jyong Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-4.67	-3.02	-4.4	-6.63	-4.2
Depreciation & Amortization	0.1	0.12	0.13	0.12	0.12
Other Adjustments	-19.21	0.76	0.55	0.6	0.85
Changes in Accounts Payable	-0	0	-0	-0.03	0.01
Changes in Accrued Expenses	21.58	0.17	0.3	-0.18	0.27
Changes in Other Operating Activities	-0.84	-1.66	0.82	3.14	0.97
Operating Cash Flow	-3.04	-3.62	-2.6	-2.97	-1.98
Capital Expenditures	-	-	-	-0.25	-0.14
Purchases of Investments	-16.87	-	-	-0.29	-1.83
Proceeds from Sale of Investments	16.87	-	0.1	1.93	0.66
Other Investing Activities	-13.51	-	-	-	-
Investing Cash Flow	-13.51	-	0.1	1.39	-1.31
Short-Term Debt Issued	23.1	9.24	9.8	11.34	5.62
Short-Term Debt Repaid	-22.94	-9.39	-9.11	-8.38	-5.57
Net Short-Term Debt Issued (Repaid)	0.16	-0.15	0.69	2.96	0.05
Long-Term Debt Issued	1.38	2.43	2.03	0.94	0.02
Long-Term Debt Repaid	-1.56	-0.07	-0.24	-0.29	-1.45
Net Long-Term Debt Issued (Repaid)	-0.18	2.36	1.78	0.65	-1.43
Issuance of Common Stock	17.77	-	-	-	-
Net Common Stock Issued (Repurchased)	17.77	-	-	-	-
Other Financing Activities	-0.11	-0.21	-0.45	-0.28	-
Financing Cash Flow	17.63	1.99	2.03	3.33	-1.38
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.01	-0.01	-0.05	-0.03	0.07
Net Cash Flow	1.08	-1.64	-0.53	1.72	-4.61
Free Cash Flow	-3.04	-3.62	-2.6	-3.22	-2.12
Free Cash Flow Per Share	-0.04	-0.05	-0.04	-0.04	-0.03
Levered Free Cash Flow	16.14	-2.18	-0.68	-0.21	-4.35
Unlevered Free Cash Flow	18.23	-3.42	-1.55	-0.02	-1.18

Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q